StonvexLoading…
StonvexStonvexStonvexCore line items from NRGV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 |
|---|---|---|---|---|
Revenue | $203.67M | $8.53M | $46.20M | $12.73M |
Operating Income | $-74.37M | $-20.89M | $-130.00M | $-79.59M |
Net Income | $-103.61M | $-21.14M | $-135.75M | $-73.92M |
EPS (Diluted) | $-0.65 | $-0.14 | $-0.91 | $-0.50 |
Total Assets | $312.88M | $217.44M | $183.89M | $252.86M |
Total Liabilities | $224.26M | $102.53M | $57.63M | $73.75M |
Cash & Equivalents | $58.26M | $17.82M | $27.09M | $51.12M |
Free Cash Flow OCF − CapEx | $-46.74M | $-9.51M | $-114.71M | $-69.35M |
Shares Outstanding | 168.97M | 154.24M | 153.21M | 151.54M |